Akers Biosciences Announces Conference Call to Discuss Fiscal Year 2017 Earnings
15. März 2018 13:11 ET
|
Akers Biosciences Inc
THOROFARE, N.J, March 15, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...
Akers Biosciences Announces Closing of $6,900,000 Public Offering
21. Dezember 2017 16:58 ET
|
Akers Biosciences Inc
THOROFARE, N.J., Dec. 21, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today...
Akers Biosciences Prices $6,000,000 Public Offering
18. Dezember 2017 22:01 ET
|
Akers Biosciences Inc
THOROFARE, N.J, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or “Akers Bio”), a developer of rapid health information technologies, today...
Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line
08. Dezember 2017 10:31 ET
|
Akers Biosciences Inc
THOROFARE, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies,...
Akers Biosciences Announces Q3 2017 Earnings
15. November 2017 07:00 ET
|
Akers Biosciences Inc
Revenues up 10% as Breathalyzers and Cholesterol Tests Begin to Contribute THOROFARE, N.J, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L),...
Akers Biosciences’ UK Distributor Secures New Channel for Rapid Alcohol Breathalyzer
14. November 2017 07:00 ET
|
Akers Biosciences Inc
Distributor Accutest Now Selling Through Today’s Group THOROFARE, N.J, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a...
Akers Biosciences Announces Conference Call to Discuss Q3 2017 Earnings
13. November 2017 09:00 ET
|
Akers Biosciences Inc
THOROFARE, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will...
Akers Biosciences to Present at Disruptive Growth & Healthcare Conference
08. Februar 2016 12:18 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), (“Akers Bio” or the "Company"), a developer of cutting edge technologies that deliver rapid...
Akers Biosciences Updates on Joint Venture in China
01. Dezember 2015 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a developer and supplier of screening and testing technologies...
Akers Biosciences to Present at 8th Annual LD Micro Investor Conference
30. November 2015 07:00 ET
|
Akers Biosciences Inc.
THOROFARE, N.J., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"), a developer of cutting edge technologies that deliver rapid health...